Medeva,
sold to Evans vaccines,
now Chiron
Vaccine companies
"A week-long inspection by the FDA last summer into the production of the flu vaccine Fluvirin at the plant found Medeva had failed to: • 'clean, maintain and sanitise equipment at appropriate intervals to prevent malfunction or contamination'; • maintain systems to prevent unacceptable levels of toxins and bacteria contaminating the production process; • ensure batches of vaccines 'conformed with all established standards, specifications and characteristics'; and • prove that vaccines on doctors' shelves would be free from 'bacteria and fungi'."--Media
[June 2002] FDA approves potentially contaminated Medeva flu vaccine for use in U.S.